Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 4 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 6Gastrointestinal 5Lymphoid 4Tumor-Agnostic 3Other hematologic neoplasm 3Thoracic 2CNS 2Sarcoma 1Plasma cell 1Other solid neoplasm 1Head & Neck 1Dermatologic 1

Conditions

Vomiting 3Nausea 3Lymphoma 3Lymphoma, Non-Hodgkin 2Neoplasms 1Multiple Myeloma 1Leukemia 1

Interventions

Cyclophosphamide 886Rituximab 864Vincristine 382Etoposide 381fludarabine 342Cytarabine 341Doxorubicin 340fludarabine phosphate 319Methotrexate 310Dexamethasone 283Prednisone 282Lenalidomide 245Filgrastim 228Melphalan 200Peripheral Blood Stem Cell Transplantation 184Radiotherapy 175Whole-Body Irradiation 172Busulfan 165Mycophenolic Acid 161venetoclax 158Bendamustine Hydrochloride 158Granulocyte Colony-Stimulating Factor 151Tacrolimus 145ibrutinib 144Bortezomib 138obinutuzumab 125Gemcitabine 113Cyclosporine 110Antilymphocyte Serum 103Carmustine 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Palonosetron × Lymphoid × Clear all
NCT01843868 2024-08-07

Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP

Australasian Leukaemia and Lymphoma Group

Phase NA Withdrawn
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Nausea, Vomiting

NCT00600353 2017-03-09

Multi-day Doses in Prevention of Nausea and Emesis

University of Kansas Medical Center

Phase 2 Completed
20 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Nausea, Neoplasms

NCT01018758 2009-11-25

NHLPal

Gruppo Italiano Studio Linfomi

Phase 2 Completed
86 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Vomiting

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡